ISTA Pharma (ISTA) Reports Positive Results from Phase 3 Study of PROLENSA, to File New NDA in 1H'12
Go back to ISTA Pharma (ISTA) Reports Positive Results from Phase 3 Study of PROLENSA, to File New NDA in 1H'12| Ista Pharmaceuticals, Inc. (NASDAQ: ISTA) | Delayed: 9.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.09 | 52 Week High | $9.11 | |||
| Open | $36.36 | 52 Week Low | $2.88 | |||
| Day High | $9.09 | P/E | 129.86 | |||
| Day Low | $9.09 | EPS | $0.07 | |||
| Volume | 1,404,196 | |||||
